𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phase I study of interleukin-12 in combination with Rituximab in patients with B-cell non-Hodgkin lymphoma

✍ Scribed by S.M. Ansell; T.E. Witzig; P.J. Kurtin; J.A. Sloan; D.F. Jelinek; K.G. Howell; S.N. Markovic; T.M. Habermann; G.G. Klee; P.J. Atherton; C. Erlichman

Book ID
117657780
Publisher
Elsevier Science
Year
2001
Tongue
English
Weight
98 KB
Volume
37
Category
Article
ISSN
0959-8049

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Phase 2 study of gemcitabine in combinat
Phase 2 study of gemcitabine in combination with rituximab in patients with recurrent or refractory Hodgkin lymphoma
✍ Yasuhiro Oki; Barbara Pro; Luis E. Fayad; Jorge Romaguera; Felipe Samaniego; Fre πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 80 KB πŸ‘ 2 views

## Abstract ## BACKGROUND. The management of recurrent or refractory Hodgkin lymphoma (HL) remains challenging. The objective of this phase 2 trial was to investigate the activity of gemcitabine in combination with rituximab in patients with recurring or refractory HL. ## METHODS. Patients were